Publications by authors named "David Coughlan"

Claim this Profile
E
Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease.
Alessandro Mattè, Enrica Federti, Antonio Recchiuti, Moayed Hamza, Giulia Ferri, David Coughlan

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of digital psychoeducation and peer support on the mental health of family carers supporting individuals with psychosis in England (COPe-support): a randomised clinical trial.
Jacqueline Sin, Claire Henderson, Jack Elkes, Victoria Cornelius, Luke A Woodham, David Coughlan

Lancet Digit Health· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers.
John Climax, Philip N Newsome, Moayed Hamza, Markus Weissbach, David Coughlan

J Am Heart Assoc· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel artemisinin-quinine hybrid with potent antimalarial activity.
John J Walsh, David Coughlan, Nicola Heneghan, Caroline Gaynor, Angus Bell

Bioorg Med Chem Lett· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis